Crsp stock forecast 2025.

Stock Price Forecast According to 16 stock analysts, the average 12-month stock price forecast for CRSP stock stock is $69.88, which predicts an increase of …

Crsp stock forecast 2025. Things To Know About Crsp stock forecast 2025.

The Upstart Holdings stock prediction for 2025 is currently $ 64.08, assuming that Upstart Holdings shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 141.45% increase in the UPST stock price.For Vaxart stock forecast for 2033 (10 year), 10 predictions are offered for each month of 2033 with average Vaxart stock forecast of $16.43, a high forecast of $18.46, and a low forecast of $12.03. The average Vaxart stock forecast 2033 represents a 2389.86% increase from the last price of $0.660000026226044. Please, see more forecasts below.The first chart below shows the global market size of CRISPR gene editing in 2019 and a forecast for 2030. The market is set to increase by a mind-boggling 1,179% to reach more than $10 billion by ...A year ago, CRISPR Therapeutics' (NASDAQ: CRSP) stock was trading for $46 per share. As of Tuesday afternoon, the biotech stock was at $64. It's easy for investors to look at that 39% rise and ...Stock Price Forecast. The 5 analysts offering 12-month price forecasts for Danimer Scientific Inc have a median target of 3.00, with a high estimate of 3.75 and a low estimate of 2.00. The median ...

Mar 9, 2021 · CRISPR Therapeutics AG Stock Prediction 2025. The CRISPR Therapeutics AG stock prediction for 2025 is currently $ 114.05, assuming that CRISPR Therapeutics AG shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 70.91% increase in the CRSP stock price. CRISPR Therapeutics AG Stock Prediction 2025. The CRISPR Therapeutics AG stock prediction for 2025 is currently $ 114.05, assuming that CRISPR Therapeutics AG shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 70.91% increase in the CRSP stock price.

CRISPR Therapeutics AG Stock (CRSP) is expected to reach an average price of $116.58 in 2025, with a high prediction of $154.57 and a low estimate of $78.58. This indicates an +78.88% rise from the last recorded price of $65.17.

If we look at the company’s services, clients and according to stock market experts, 1st tdoc stock forecast 2025 can go up to 170.89 USD and 2nd tdoc stock price target is 192.75 USD in 2025, Teladoc Inc. has divided its services into 6 parts which include guidance and support, expert medical services, mental health services, platform and ...December 2025. Festive spending and end-of-year portfolio adjustments might lead VOO to end on a high note. Predicted Price Range: $450-$470. In the realm of investments, understanding potential trajectories like this can be empowering. Yet, always remember that these are speculative figures.The average Editas Medicine stock forecast 2024 represents a 3.79% increase from the last price of $10.5299997329712. For Editas Medicine stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Editas Medicine stock forecast of $10.98, a high forecast of $12.02, and a low forecast of $10.15.According to Wall Street's consensus estimates, these four stocks are forecast to increase sales by 25,750% to as much as 2,970,000% (that's nearly 3 million percent) over the next five years.

CRSP - CRISPR Therapeutics Stock Prediction 2025 - 2030 + Portfolio 7 years of reliable CRISPR Therapeutics stock forecast. The Wall Street analysts predict Outperform for CRSP. See at a glance whether NasdaqGM:CRSP will rise in the future. $41.47 Forecast 2023 $49.60 Forecast 2025 $77.58 Forecast 2030 Underperform TopGraphs Quality Ranking

Among the leaders in the nascent CRISPR space are biotech stocks like CRISPR Therapeutics, (CRSP 2.88%) Editas Medicine, and Intellia Therapeutics. These companies have pipelines that are jam ...

Sep 30, 2021 · According to Wall Street's consensus estimates, these four stocks are forecast to increase sales by 25,750% to as much as 2,970,000% (that's nearly 3 million percent) over the next five years. That's an eye catching number but take a step back and think about it. We hit $5.00 last week. If it doubles in 2021 that's $10.00 and if it doubles again in 2 years by 2023 that's $20.00 leaving 2024 for 30% growth to 26.00. In a growing EV market, with a fully differentiated product.1 CRSP® is a registered trademark and service mark of Center for Research in Security Prices, LLC and has been licensed for use by D&P/Kroll. The D&P/Kroll publications and services are not sponsored, sold or promoted by CRSP®, its affiliates or its parent company. To learn more about CRSP, visit www.crsp.com. 2 Depending on subscription level. YNov 20, 2023 · The mean of analysts' price targets for CRISPR Therapeutics AG (CRSP) points to a 33.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ... 1 CRSP® is a registered trademark and service mark of Center for Research in Security Prices, LLC and has been licensed for use by D&P/Kroll. The D&P/Kroll publications and services are not sponsored, sold or promoted by CRSP®, its affiliates or its parent company. To learn more about CRSP, visit www.crsp.com. 2 Depending on subscription level. YStock Price Forecast. The 12 analysts offering 12-month price forecasts for Shell PLC have a median target of 75.10, with a high estimate of 88.00 and a low estimate of 66.00. The median estimate ...How much will CRISPR Therapeutics cost in 2021 – 2025? Forecast: (CRSP) for today November 26 & Weekly Forecast from 19 November to 2 December Price Prediction …

Nov 28, 2023 · CRISPR Therapeutics (CRSP) stock forecast for 2025 Last update: November 21, 2023 (07:48) Sector: Healthcare The share price of CRISPR Therapeutics AG (CRSP) now CRISPR Therapeutics AG 69.97 D 0.74% (0.52) What analysts predict: $87.78 52-week High/Low: $76.19 / $37.55 50/200 Day Moving Average: $46.64 / $51.55 Nov 28, 2023 · CRISPR Therapeutics (CRSP) stock forecast for 2025 Last update: November 21, 2023 (07:48) Sector: Healthcare The share price of CRISPR Therapeutics AG (CRSP) now CRISPR Therapeutics AG 69.97 D 0.74% (0.52) What analysts predict: $87.78 52-week High/Low: $76.19 / $37.55 50/200 Day Moving Average: $46.64 / $51.55 CRSP - CRISPR Therapeutics AG Stock - Stock Price, Institutional Ownership, Shareholders (NASDAQ)Casper Sleep Inc. (NYSE:CSPR) announced its quarterly earnings results on Monday, November, 15th. The company reported ($0.61) earnings per share for the quarter, missing the consensus estimate of ($0.43) by $0.18. The company had revenue of $156.50 million for the quarter, compared to analyst estimates of $156.15 million.Nikola Stock Forecast, NKLA stock price prediction. Price target in 14 days: 1.060 USD. ... Nikola Corp Stock Price Forecast for 2025: January 2025: Open: 0.000001 ...

Exela Technologies, Inc. (NASDAQ:XELA) issued its quarterly earnings results on Friday, November, 5th. The company reported ($1,080.00) earnings per share for the quarter, missing the consensus estimate of ($680.00) by $400.00. The business had revenue of $279.23 million for the quarter, compared to analysts' expectations of $310 …Oct 10, 2023 · CRISPR Therapeutics Stock Forecast 2023. In the last five quarters, CRISPR Therapeutics’s Price Target has risen from $0.00 to $40.65 - a 100% increase. One analysts predict that CRISPR Therapeutics’s share price will increase in the coming year, reaching $150.00. This would represent an increase of 269%.

Stock Price Forecast. The 3 analysts offering 12-month price forecasts for Inseego Corp have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate ...CRSP - CRISPR Therapeutics Stock Prediction 2025 - 2030 + Portfolio 7 years of reliable CRISPR Therapeutics stock forecast. The Wall Street analysts predict …Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Adobe Inc. (NASDAQ:ADBE) announced its quarterly earnings data on Thursday, September, 14th. The software company reported $4.09 EPS for the quarter, topping the consensus estimate of $3.98 by $0.11. The software company had revenue of $4.89 billion for the quarter, compared to analysts' expectations of $4.87 billion.CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.Upgrade: " Piper Sandler analyst Edward Tenthoff with an overweight recommendation and $180 per share target on CRISPR (CRSP), urges investors to buy the dip. Tenthoff argues that data “validate CTX110 and CRISPR’s allogeneic CAR-T pipeline” with the company planning to expand the study." I agree with this guy!:-) 6.CRISPR Therapeutics AG Stock Forecast, CRSP stock price prediction. Price target in 14 days: 83.094 USD. ... CRISPR Therapeutics AG Stock Price Forecast for 2025 ...How much will CRISPR Therapeutics cost in 2021 – 2025? Forecast: (CRSP) for today November 26 & Weekly Forecast from 19 November to 2 December Price Prediction …Dec 1, 2023 · According to 16 stock analysts, the average 12-month stock price forecast for CRSP stock stock is $69.88, which predicts an increase of 1.79%. The lowest target is $42 and the highest is $110. On average, analysts rate CRSP stock stock as a buy. Analyst Consensus: Buy Analyst Ratings

Oct 27, 2023 · Unraveling CRISPR Therapeutics (CRSP) Stock Predictions for 2024 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing CRISPR Therapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.

Price Prediction CRISPR Therapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.

Lithium Americas stock prediction for December 2024. In the beginning at 5.79. Maximum 6.00, minimum 5.12. The averaged price 5.62. At the end of the month 5.56 dollars, change for December -4.0%. Lithium Americas stock price forecast for January 2025. In the beginning at 5.56. Maximum 6.43, minimum 5.47.View the latest CRISPR Therapeutics AG (CRSP) stock price, news, historical charts, analyst ratings and financial information from WSJ.Target values for the price of one CRISPR Therapeutics share for Feb 2024. The weighted average target price per CRISPR Therapeutics share in Feb 2024 is: 73.57. In Feb, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 7.132% volatility is expected. Pessimistic target level: 70.51.The latest CRISPR Therapeutics stock prices, stock quotes, news, and CRSP history to help you invest and trade smarter. ... The 68 analysts offering price forecasts for CRISPR Therapeutics have a ...CRISPR Therapeutics (CRSP) Stock Forecast & Price Target $66.73 -2.36 (-3.42%) (As of 04:00 PM ET) Compare Today's Range $66.51 $71.18 50-Day Range …The average CRISPR Therapeutics AG stock forecast 2024 represents a -25.46% decrease from the last price of $68.6500015258789. For CRISPR Therapeutics AG stock forecast for 2025, 12 predictions are offered for each month of 2025 with average CRISPR Therapeutics AG stock forecast of $49.41, a high forecast of $51.16, and a low forecast of $46.49. If we look at the company’s services, clients and according to stock market experts, 1st tdoc stock forecast 2025 can go up to 170.89 USD and 2nd tdoc stock price target is 192.75 USD in 2025, Teladoc Inc. has divided its services into 6 parts which include guidance and support, expert medical services, mental health services, platform and ...CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew …Dec 1, 2023 · According to 16 stock analysts, the average 12-month stock price forecast for CRSP stock stock is $69.88, which predicts an increase of 1.79%. The lowest target is $42 and the highest is $110. On average, analysts rate CRSP stock stock as a buy. Analyst Consensus: Buy Analyst Ratings See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

Find real-time EDIT - Editas Medicine Inc stock quotes, company profile, news and forecasts from CNN Business.KYN Capital Group Inc () Stock Market info Recommendations: Buy or sell KYN Capital Group stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the KYN Capital Group share forecasts, stock quote and buy / sell signals below.According to present data KYN Capital Group's KYNC shares and potentially its …CRSP - CRISPR Therapeutics Stock Prediction 2025 - 2030 + Portfolio 7 years of reliable CRISPR Therapeutics stock forecast. The Wall Street analysts predict …Instagram:https://instagram. real time after hours stock quotesrules for inherited irasschd etf reviewstock market plumbing After this upgrade, CRISPR Therapeutics' 28 analysts are now forecasting revenues of US$239m in 2023. This would be a sizeable 40% improvement in sales compared to the last 12 months. Losses are ...For Editas Medicine stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Editas Medicine stock forecast of $8.2, a high forecast of $8.21, and a low forecast of $8.19. The average Editas Medicine stock forecast 2031 represents a 4.21% increase from the last price of $7.86999988555908. applied genetic technologies corporationamerican express dividend On Friday, right after Thanksgiving Day, shares opened at $111.08, the stock price hovered over $120 to a new high of $124.43 before closing at $121.55 – a good 10.5% gain from the previous ...Find the latest CRISPR Therapeutics AG CRSP analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating. 1804 american silver dollar Target values for the price of one Clover Health Investments share for Nov 2025. The weighted average target price per Clover Health Investments share in Nov 2025 is: 2.33. In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 22.238% volatility is expected. Pessimistic target level: 2.00.Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...And one particular stock to benefit is biotech CRISPR Therapeutics (CRSP 0.92%). The stock has advanced 24% so far this year. And this innovative company could be at the very beginning of its ...